COVID-19 vaccine weekly safety report (27 May 2021)

27 May 2021 - Nine additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

COVID-19 vaccine weekly safety report

20 May 2021 - Six additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...

Read more →

ICER releases draft evidence report on therapies for atopic dermatitis

14 May 2021 - Public comment period now open until 11 June 2021; requests to make oral comment during public meeting ...

Read more →

ICER publishes final evidence report and policy recommendations on therapies for multiple myeloma

11 May 2021 - Independent appraisal committee unanimously determined the evidence is adequate to demonstrate that CAR-T treatments ide-cel and cilta-cel ...

Read more →

Public Summary Documents (rejections/deferrals/other matters) - December 2020 PBAC intracycle meeting

23 April 2021 - The Public Summary Documents (rejections/deferrals/other matters) from the December 2020 PBAC intracycle meeting are now available. ...

Read more →

TGA publishes AusPAR for Zolgensma

22 April 2021 - Rapid publication following approval. ...

Read more →

ICER publishes final evidence report and policy recommendations on therapies for lupus nephritis

16 April 2021 - For belimumab and voclosporin, independent appraisal committee votes highlight the importance of several potential benefits of both ...

Read more →

PBAC Public Summary Documents - December 2020 intracycle meeting

9 April 2021 - The Public Summary Documents (positive recommendations) from the December 2020 PBAC intracycle meeting are now available. ...

Read more →

PBAC publishes sham Public Summary Document for upadacitinib

22 March 2021 - The outcome section makes absolutely no reference to the issue at hand. ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) - November 2020 meeting

19 March 2021 - The Public Summary Documents (first time rejections and deferrals) from the November 2020 PBAC meeting are now ...

Read more →

Drug Utilisation Sub-Committee outcome statement

18 March 2021 - The outcome statement from the February 2021 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

PBAC updates Public Summary Document for medicine without a published outcome

11 March 2021 - The Department of Health has updated the Public Summary Document for adalimumab (Humira) from the July ...

Read more →

PBAC Public Summary Documents - November 2020 meeting

5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...

Read more →

Post-market review of medicines for smoking cessation – stakeholder forum outcome

15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...

Read more →

ICER publishes evidence report on roxadustat for treating anaemia in chronic kidney disease

28 January 2021 - Other than a proven ability to reduce the need for intravenous iron supplements, the evidence is insufficient ...

Read more →